POSTER SESSION I Monday, February 13, 2006   —  9:30 AM - 12:00 Noon Exhibit Level HEMATOPATHOLOGY 135 Chemokine Receptor CXCR4 (Fusin) Is A Poor Prognostic Factor In Diffuse Large B-Cell Lymphoma (1001) MS Almiski, F Khanani, O Basturk, VN Adsay, MO Kurrer, E Levi - Harper Hospital, Wayne State University, John D Dingell VamC, Detroit, MI; University Hospital, Zurich, Switzerland 136 Detection of CD4, CD25, and CD152: A New Role for Flow Cytometry in the Diagnosis of Hodgkin Lymphoma? (1009) DS Bosler, VK Douglas-Nikitin, MD Smith - William Beaumont Hospital, Royal Oak, MI 137 Clinical Implications of Quantitative and Qualitative Post-treatment Detection of amL1-ETO in amL (1014) L Chen, J Guo, D Jones, R Luthra, P Lin - The University of Texas MD Anderson Cancer Center, Houston, TX 138 The Architectural Pattern of FOXP3+ T Cells Is an Independent Predictor of Survival in Patients with Follicular Lymphoma (FL) (1043) P Farinha, E Campo, A Banham, H Masoudi, B Skinnider, JM Connors, K Shumansky, J Spinelli, RD Gascoyne - BC Cancer Agency, Vancouver, BC, Canada; Hospital Clinic, Barcelona, Spain; John Radcliffe Hospital, Oxford, United Kingdom; BCCA; BCCA, Canada 139 Simultaneous JAK2 V617F and KIT D816V Mutations in Systemic Mastocytosis (1048) CD Galderisi, CL Corless, J Wolford, T Harrell, MC Heinrich, RD Press - Oregon Health and Science University, Portland, OR 140 Expression of B-cell Transcription Factors in Acute Myeloid Leukemia (1057) SE Gibson, ED Hsi - Cleveland Clinic Foundation, Cleveland, OH 141 Non-Hodgkin Lymphoma Showing Abnormalities Of C-Myc Including Dual Translocations Involving C-Myc And Bcl2: A Clinicopathologic Study. (1072) R Jastania, V Kukreti, K Chun, M Al Shraim, D Bailey, B Patterson, M Crump, S Boerner, W Geddie - University Health Network, Toronto, ON, Canada 142 Mixed Lineage Kinase-3 (MLK3) Expression Is A Poor Prognostic Factor In Diffuse Large B-Cell Lymphoma, Associated With An Activated B-Cell Subtype (1083) F Khanani, MS Almiski, O Basturk, J Frank, MO Kurrer, E Levi - Harper Hospital, Wayne State University, John D Dingell VamC, Detroit, MI; University Hospital, Zurich, Switzerland 143 Frequency Of BCL2 Breakpoints In Follicular Lymphoma And Correlation With Histologic Grade (1094) MR Mariappan, C Shum, DA Arber - Stanford University Medical Center, Stanford, CA 144 JAK2 V617 Mutational Analysis For The Diagnostic Work-Up Of Chronic Myeloproliferative Disorders. (1098) C McMahon, JA Kant, FE Craig, SH Swerdlow, SA Monaghan - University of Pittsburgh School of Medicine, Pittsburgh, PA 145 Prognostic Significance of Bcl-2 and Bcl-6 Expression in Patients with Nodular Sclerosis Hodgkin Lymphoma (NSHL) (1109) H Naushad, P Aoun, LM Smith, Z Pan, P Bierman, TC Greiner, WC Chan, DD Weisenburger - University of Nebraska Medical Center, Omaha, NE 146 Co-expression of CD15 and CD30 in Anaplastic Large Cell Lymphoma (1110) V Neppalli, K Fu, WC Chan, TC Greiner, DD Weisenburger, P Aoun - University of Nebraska Medical Center, Omaha, NE 147 Development Of A Real Time PCR Assay For The JAK2 V617F Mutation In Myeloproliferative Disorders (1115) RJ Olsen, D Tang, DW Bernard, DH Farkas, JCC Chang - Baylor College of Medicine, The Methodist Hospital, Houston, TX; Cornell University, Ithica, NY 148 Polymorphisms Affecting The Expression Of Certain Cytokines Associate With The Myelodysplastic Syndromes (1120) MP Powers, A Raza, H Nishino, Y Lou, CC Chang - The Methodist Hospital and Weill Cornell Medical School, University of Houston, BCM, Houston, TX 149 Phenotypic Analysis Of T Cell Acute Lymphoblastic Leukemias With Genetic Alteration Of The TAL1 Locus (1134) ER Rudzinski, Q Wang, S Olsen, MA Thompson - Vanderbilt University Medical Center, Nashville, TN 150 CD30 Positive Cells In Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL): A Clinicopathologic Evaluation. (1140) RM Seliem, WL Wang, RP Hasserjian, JA Ferry, NL Harris, LR Zukerberg - Massachusetts General Hospital, Boston, MA 151 Appropriate Categorization Of High Grade B-Cell Lymphomas With Classical Burkitt Morphology But Lacking MYC Translocation. (1141) DW Sevilla, JZ Gong, BK Goodman, PJ Buckley, AS Lagoo - Duke University Medical Center, Durham, NC 152 Decrease of p38 MAPK Activation in Myeloproliferative Disorders (1142) M Shahjahan, CH Dunphy, N Singhal, L Garza, Y Zu, C Chang - The Methodist Hospital, Houston, TX; University of North Carolina, Chapel Hill, NC 153 Effects of Rituximab on the Immunophenotype of Benign B-cell Precursors: Implications for Flow Cytometric Minimal Residual Disease Detection in Precursor B-Acute Lymphoblastic Leukemia (1143) K Siami, S Awagu, DG Cooper, DA Thomas, Y Huh, D Jones, W Chen, JL Jorgensen - UTMDACC, Houston, TX 154 ZAP70 Expression In CLL-A Correlative Study Using Flow Cytometry, Immunocytochemistry And Western Blot Analysis (1144) GW Slack, J Wizniak, L Dabbagh, X Shi, R Lai - University of Alberta, Cross Cancer Institute, Edmonton, AB, Canada 155 Plasma Cell Dyscrasias: Flow Cytometric Vs Histologic Detection, How Do They Compare? (1147) JH Smouse, DM Dorfman, J Vergilio - Brigham and Women's Hospital, Boston, MA 156 Downregulation of MCl-1 and Induction of Apoptosis in Mantle Cell Lymphoma by Flavopiridol (Pan CDK4 Inhibitor) (1159) G Venkataraman, T Maududi, F OzPuyan, HI Bahar, J Qin, KF Izban, S Alkan - Loyola University Medical Center, Maywood, IL; Elmhurst Memorial Hospital, Elmhurst, IL 157 Utility Of PAX-5 Immunohistochemistry To Assess Bone Marrow Involvement By B-Cell Malignancy In The Setting Of Anti-CD20 Therapy And Its Expression In A Variety Of Bone Marrow Disorders. (1161) DM Vlasoff, WG Morice, JD Hoyer - Mayo Clinic, Rochester, MN 158 Comprehensive Proteomic Analysis of Reed-Sternberg Cells (1163) JC Wallentine, KK Kim, C Seiler, DK Crockett, SR Tripp, KSJ Elenitoba-Johnson, MS Lim - University of Utah School of Medicine, ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 159 Significance of Cytogenetic and Immunophenotypic Findings in Patients with Acute Myeloid Leukemia Evolving from Myelodysplastic Syndrome (1165) JS Warrington, MJ Routbort, PJ Buckley, JZ Gong, BK Goodman, AS Lagoo - Duke University Medical Center, Durham, NC